Skip to content

Mercaptopurine

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Also known as: 6-mercaptopurine, 6-mercaptopurine monohydrate, mercaptopurine hydrate, mercaptopurine monohydrate, mercapurin, purimethol, purinethiol, purinethol, thiohypoxanthine, xaluprine

OfpFDA approvedATC L01BB02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Mercaptopurine is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 1953. DrugCentral lists 7 molecular targets, including PTGS1, punA and ABCC4. Recorded indications include Acute lymphoid leukemia and Acute promyelocytic leukemia, FAB M3.

  • Approval status: ofp (first approved 1953 by the FDA).
  • Molecular targets: PTGS1, punA, ABCC4 and PPAT (7 listed in DrugCentral).
  • Indications: Acute lymphoid leukemia and Acute promyelocytic leukemia, FAB M3.
  • ATC code: L01BB02 (Purine analogues).
  • Molecular formula: C5H4N4S; molecular weight 152.18 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Acute lymphoid leukemia
  • Acute promyelocytic leukemia, FAB M3

Off-label uses (5)

  • Acute myeloid leukemia, disease
  • Crohn's disease
  • Polycythemia vera
  • Psoriasis with arthropathy
  • Ulcerative colitis

Contraindications (19)

  • Acute pancreatitis
  • Anemia
  • Ascites
  • Bone marrow depression
  • Breastfeeding (mother)
  • Chemotherapy-Induced Hyperuricemia
  • Dehydration
  • Disease of liver
  • Gastrointestinal ulcer
  • Hepatosplenic T-cell lymphoma
  • Hyperbilirubinemia
  • Kidney disease
  • Leukopenia
  • Liver function tests abnormal
  • Neutropenic disorder
  • Obstruction of bile duct
  • Pregnancy, function
  • Thiopurine S-Methyltransferase Deficiency
  • Thrombocytopenic disorder

Mechanism & targets

Molecular targets (7)

TargetGeneActionActivity
Prostaglandin G/H synthase 1PTGS1unknownIC50 4.79
Purine nucleoside phosphorylasepunAunknownKd 4.10
Multidrug resistance-associated protein 4ABCC4unknown—
AmidophosphoribosyltransferasePPATinhibitor—
Thiopurine S-methyltransferaseTPMTunknown—
Purine nucleoside phosphorylasePNPunknown—
Multidrug resistance-associated protein 5ABCC5unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1953-09-11FDA—STASON PHARMS

ATC classification

ATC codeTherapeutic hierarchy
L01BB02ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › ANTIMETABOLITES › Purine analogues

Pharmacogenomics

Drug-label and guideline annotations from PharmGKB and CPIC.

  • EMA label: NUDT15, TPMT · Testing Recommended
  • FDA label: NUDT15, TPMT · Testing Recommended
  • HCSC label: NUDT15, TPMT · Testing Recommended
  • Swissmedic label: NUDT15, TPMT · Actionable PGx

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Febrile neutropenia2856.4
Febrile bone marrow aplasia807.5
Secondary immunodeficiency538.4
Venoocclusive liver disease520.2
Bacterial infection450.7
Mycobacterium chelonae infection443.3
Hypertriglyceridaemia417.0
Human bocavirus infection413.5
Rhinovirus infection406.5
Acute lymphocytic leukaemia recurrent405.4
Myelosuppression375.1
Pancytopenia364.3

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Mercaptopurine is on its molecule page.

Molecular formulaC5H4N4S
Molecular weight152.18 g/mol
CAS number50-44-2
InChIKeyGLVAUDGFNGKCSF-UHFFFAOYSA-N
PubChem CID667490
S=C1N=CNC2=C1NC=N2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Mercaptopurine used for?

DrugCentral lists the following indications for Mercaptopurine: Acute lymphoid leukemia and Acute promyelocytic leukemia, FAB M3.

How does Mercaptopurine work?

Its molecular targets in DrugCentral include PTGS1, punA, ABCC4 and PPAT (inhibitor).

When was Mercaptopurine first approved?

Mercaptopurine was first approved by the FDA in 1953.

What is the chemical formula of Mercaptopurine?

Mercaptopurine has the molecular formula C5H4N4S and a molecular weight of 152.18 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1953-09-11
AgencyFDA
Targets7
Indications2
FormulaC5H4N4S
DrugCentral ID1708
Interactive profile